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The slow growth rate and genetic intractability of tubercle bacilli
has hindered progress toward understanding tuberculosis, one of
the most frequent causes of death worldwide. We overcame this
roadblock through development of near-infrared (NIR) ﬂuorogenic
substrates for β-lactamase, an enzyme expressed by tubercle bacilli,
but not by their eukaryotic hosts, to allow real-time imaging of
pulmonary infections and rapid quantiﬁcation of bacteria in living
animals by a strategy called reporter enzyme ﬂuorescence (REF).
This strategy has a detection limit of 6 ± 2 × 102 colony-forming
units (CFU) of bacteria with the NIR substrate CNIR5 in only 24 h of
incubation in vitro, and as few as 104 CFU in the lungs of live mice.
REF can also be used to differentiate infected from uninfectedmac-
rophages by using confocal microscopy and ﬂuorescence activated
cell sorting.Mycobacterium tuberculosis and the bacillus Calmette–
Guérin can be tracked directly in the lungs of living mice without
sacriﬁcing the animals. Therapeutic efﬁcacy can also be evaluated
through loss of REF signal within 24 h posttreatment by using in
vitro whole-bacteria assays directly in living mice. We expect that
rapid quantiﬁcation of bacteriawithin tissues of a living host and in
the laboratory is potentially transformative for tuberculosis viru-
lence studies, evaluation of therapeutics, and efﬁcacy of vaccine
candidates. This is a unique use of an endogenous bacterial enzyme
probe to detect and image tubercle bacilli that demonstrates REF
is likely to be useful for the study of many bacterial infections.
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Tuberculosis, caused by Mycobacterium tuberculosis (Mtb),remains one of the most frequent causes of death in humans
worldwide by killing nearly 2 million people each year (1).
Emergence of strains resistant to multiple drugs has led to sit-
uations where treatment is no better than before the discovery of
antibiotics (2, 3). Diagnosis of tuberculosis remains a major bar-
rier to control of the disease because the standard method, the
acid-fast smear using sputum, does not become positive until a few
months after transmission occurs. Culture-based techniques are
more sensitive, but still take weeks to obtain results. Similar
problems plague tuberculosis research in general, and particularly
in animal models, where data from assays is dependent upon
determination of colony-forming units (CFU). This problem
impacts the pace of virulence studies, evaluation of therapeutics,
and development of vaccines. All tuberculosis research and di-
agnosis would be facilitated by methods to detect tubercle bacilli
in vitro and during disease. Although recombinant reporter strains
of mycobacteria have been developed for detection of mycobac-
teria using ﬂuorescence, luminescence (4–8), and even single
photon emission computed tomography (SPECT) (9, 10), these
methods require speciﬁc laboratory strains and do not allow de-
tection of pulmonary tuberculosis by optical imaging directly in
live animals. Recombinant systems have facilitated progress, but
expression of a foreign gene can impact bacterial ﬁtness in un-
expected ways, particularly when expressed from plasmids
(11–13). The ability to detect all strains that cause tuberculosis
directly without expression of foreign genes would have a pro-
found impact upon the tuberculosis ﬁeld and would facilitate re-
search with clinical strains that cause tuberculosis. Sensitive
detection of nonrecombinant strains that cause tuberculosis can
also improve clinical diagnosis using sputum and other diagnostic
samples as well as ultimately be applied directly to diagnosis of
infections in patients.
We describe noninvasive detection of natural strains that cause
pulmonary tuberculosis in living animals. Detection is based on re-
porter enzyme ﬂuorescence (REF) technology, which uses β-
lactamase, a naturally occurring enzyme expressed byMtb (14, 15),
as the reporter enzyme and uniqueﬂuorogenic substrate probes for
imaging. Although optical probes for endogenous enzymes have
been used to differentiate cancerous tissue from normal tissue in
the ﬁeld of oncology (16), they have not been used for infectious
diseases where, due to the presence of enzymatic targets that are
unique to pathogens, this approach has the potential for exquisite
speciﬁcity. A great deal is known about β-lactamase enzymes and
substrates because they are the most common mechanism of bac-
terial resistance to penicillin and cephalosporin antibiotics through
hydrolysis of a β-lactam ring (17–20). Comparison of the crystal
structure of theMtb β-lactamase, BlaC, to that of other similar en-
zymes, such as theEscherichia coli β-lactamaseTEM-1, reveals that
BlaC has an unusually large active site pocket, suggesting that de-
sign of substrates with high speciﬁcity should be straightforward
(21).Considering that catalytic reporters canproduce ameasurable
signal at 1,000-fold lower protein levels than ﬂuorescent proteins
(22), β-lactamase REF has the potential for extremely high sensi-
tivity. These characteristics, along with the very high catalytic ac-
tivity (23) of β-lactamase, make this enzyme a nearly ideal choice
for development of speciﬁc probes to detect tuberculosis in the
laboratory, live animals, or patients.
Results
Expression of β-Lactamase by Mtb. We evaluated the expression of
β-lactamase in different strains that cause tuberculosis. All strains
ofMtb examined express BlaC at levels measurable within 2 h and
increasing in signal intensity to 20 h (Fig. 1A). As expected,
a speciﬁc mutant in Mtb blaC (24) produces greater than 10-fold
lower levels of signal, indicating that BlaC is responsible for the
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majority of β-lactamase activity inMtb. TheMtb BlaC is primarily
surface-localized because membrane fractions carry the majority
of the activity (Fig. 1B). The fact that the Mtb BlaC is surface-
localized makes it a nearly ideal candidate for use to detect Mtb
because substrates would not have to traverse the bacterial cell
wall. This is a signiﬁcant issue for detection of mycobacteria be-
cause their cell wall is thought to be highly selective.
Substrates for Detection of Mtb β-Lactamase. We have developed
substrates that are eukaryotic cell permeable and produce a long
wavelength ﬂuorescent signal when cleaved that is amenable to use
in live animal imaging due to the ability of long wavelengths to
penetrate mammalian tissue efﬁciently (25, 26). To detect Mtb us-
ing BlaC, we designed several near-infrared ﬂuorogenic substrates:
CNIR4,CNIR5,CNIR9, andCNIR10 (Fig. S1a). These “molecular
switches” or “beacons” are not ﬂuorescent before cleavage due to
thepresence of a quencher,QSY21or its derivative, linked to either
Cy5 (CNIR4) or Cy5.5 (CNIR5, CNIR9, and CNIR10) through
a lactam ring, leading to a ﬂuorescence resonance energy transfer
(FRET) quenching effect (Fig. 2). BlaC cleavage triggers sponta-
neous fragmentation, releasing the quencher connected to the 3′
position of the lactam, breaking the FRET process, and restoring
ﬂuorescence emission. The quencherQSY21wasmodiﬁed tomake
a hydrophilic QSY21 disulfonate that absorbs maximally at 649 nm
and a hydrophobic QSY22 that absorbs maximally at 670 nm to
allow optimal quenching of Cy5 and Cy5.5, respectively. We con-
nected acetylated D-glucosamine to the carboxylate of cysteine
through a γ-amino-butyric acid as the linker in CNIR5 and CNIR9
because we have shown that fully acetylated glucosamine can fa-
cilitate uptake of the highly charged CNIR4 into eukaryotic cells
(25). We designed CNIR10 without the D-glucosamine to directly
evaluate the impact of a smaller, less charged probe.All four probes
display little ﬂuorescence before β-lactamase cleavage and an in-
crease in maximal emission by 8.5- (660 nm, CNIR4), 24- (690 nm,
CNIR5), 9.5- (690 nm, CNIR9), and 10-fold (690 nm, CNIR10)
after cleavage (Fig. S1b). We found that coincubation of each of
these probes with Mtb resulted in direct labeling of the bacteria,
with an increase in ﬂuorescence of 2-fold for CNIR4, 3-fold for
CNIR5, 1.5-fold for CNIR9, and 2-fold for CNIR10 after 18 h
coincubation (Fig. S1C).
Detection and Quantiﬁcation of Mtb in Vitro. In the case of CNIR5,
which displays the greatest increase in ﬂuorescence during coin-
cubation with Mtb, we found a good correlation (r2 = 0.989) be-
tween bacterial numbers and level of ﬂuorescence over a broad
range of bacteria from 102 to 106 colony forming units (Fig. 3A).
The calculated limit of detection using CNIR5 was 6 ± 2 × 102
CFU. The calculated limit of detection using CNIR5 for other
β-lactamase–producing bacteria was similar: 6 ± 1 × 102 CFU for
Pseudomonas aeruginosa and 8 ± 0.7 × 102 CFU for Staphylo-
coccus aureus. Incorporation of the ﬂuorescent dye into Mtb was
conﬁrmed by ﬂuorescence confocal microscopy at 24 h coincu-
bation whereas Mtb in the absence of CNIR does not display
ﬂuorescence at 690 nm (Fig. 3B). Mtb within macrophages could
also be detected with CNIR, and there is a good correlation (r2 =
0.984) between bacterial numbers and ﬂuorescence intensity
(Fig. 3C), with a threshold of detection of 1–5 × 105 bacteria.
Interestingly, the most intense staining with all four CNIR sub-
strates is within compartments in the cytoplasm of macrophages,
suggesting that these substrates efﬁciently penetrate subcellular
compartments and that the majority of the active Mtb BlaC is
accessible to substrate outside of the bacteria (Fig. 3D), which is
consistent with our fractionation studies. CNIR labeling allows
direct detection of infected versus uninfected macrophages using
microscopy, a useful tool for studies with tissue culture cells.
Cytotoxicity of these substrates was examined as described pre-
viously (27) in J774A.1 cells, and no signiﬁcant cytotoxicity occurs
with concentrations up to 100-fold higher than those used
for detection of Mtb. We also found that CNIR can be used to
differentiate infected from uninfected cells by ﬂuorescence-
activated cell sorting (FACS; Fig. 3E), making it possible to
quantify infected cells during in vitro studies or in homogenized
tissues from animal studies. The number of cells separated by
FACS using either recombinant green ﬂuorescent protein (GFP)
or CNIR was similar and correlated with the multiplicity of in-
fection (MOI) used.
Real-Time Analysis of Tuberculosis in Living Animals. These obser-
vations indicate that Mtb can be detected and quantiﬁed using
REF, but do not address whether CNIR will allow detection di-
rectly in animals. To establish the kinetics of CNIR substrates for
quantiﬁcation of Mtb in mammalian tissues, we infected BALB/c
mice by s.c. inoculation with Mtb and the closely related vaccine
strain bacillus Calmette–Guérin. We found that CNIR4, CNIR5,
CNIR9, and CNIR10 could detect 107 s.c. bacteria and CNIR5
could readily detect 106 bacteria (Fig. 4). Maximal ﬂuorescence
is observed at 48 h postadministration of the substrate with CNIR5
producing the highest levels of signal followed by CNIR10,
CNIR4, and CNIR9. Fluorescent signal is not signiﬁcantly differ-
ent from background for any substrate after 96 h postadministra-
tion, allowing the substrate to be readministered to the same
animals for subsequent imaging. Both bacillus Calmette–Guérin-
and Mtb-infected animals display nearly identical kinetics and
signal strength with all CNIR substrates. The improved signal
observed for CNIR5 over CNIR4 is most likely due to the bene-
ﬁcial characteristics of the longer wavelength of excitation and
emission for Cy5.5 over Cy5, but the lower signals of CNIR9 and
CNIR10 are likely the result of differences in their membrane
Fig. 1. Mycobacterium tuberculosis (Mtb) strains produce a membrane-
localized β-lactamase. (A) The three common laboratory Mtb strains H37Rv,
CDC1551, and Erdman all produce similar levels of β-lactamase as measured by
the change in ﬂuorescence of Fluorocillin Green (excitation: 485 nm; emission:
530 nm) in the presence of 107 bacteria. In the case of CDC1551, the signal
produced is signiﬁcantly lower (***P < 0.001) than Erdman and H37Rv, yet it
is at least 10-fold higher than background. The H37Rv blaCm strain with
a mutation in the blaC gene displays negligible β-lactamase activity. (B) Mem-
brane fractions of Mtb are responsible for the majority of the β-lactamase ac-
tivity found inwhole-cell fractions, suggesting that BlaC is primarilymembrane-
localized in Mtb. β-Lactamase levels in culture ﬁltrates are signiﬁcantly higher
than background (P < 0.001), indicating that BlaC is secreted at low levels.
Fig. 2. Reporter enzyme ﬂuorescence detection of M. tuberculosis with
near-infrared (CNIR) ﬂuorogenic substrates. The intact CNIR substrates do not
display ﬂuorescence due to the close proximity of the ﬂuorescent dye (Cy5 or
Cy5.5) and the quencher through ﬂuorescence resonance energy transfer
(FRET), but become ﬂuorescent after hydrolysis by β-lactamase, generating
the ﬂuorescent product whose emission can be measured using a ﬂuorome-
ter. The quencher groups used are QSY21 or derivatives and the CNIR dyes are
Cy5 (CNIR4) and Cy5.5 (CNIR5, CNIR9, and CNIR10). NIR, near-infrared.
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permeability. This conclusion is supported by the lower incor-
poration of ﬂuorescence into the bacteria over time observed for
both CNIR9 and CNIR10 compared with CNIR5 (Fig. S1C). Al-
though acetylated glucosamine improves uptake of these sub-
strates, the sulfates also play an unexpected role in improving the
observed imaging kinetics that cannot be compensated for by the
lower molecular weight of CNIR10.
Localization and Quantiﬁcation of Pulmonary Infection. Pulmonary
infection is the natural route of infection by Mtb, but the greater
tissue depth and complexity of the lung make detection more difﬁ-
cult. We infected mouse lungs with bacillus Calmette–Guérin and
Mtb and imaged them by transillumination after administration of
CNIR5 for REF. At both 24 and 48 h postadministration of CNIR5,
as few as 104 CFU could be detected in the lungs of living mice
(Fig. 5 A and C). Although the signal correlates well with bacterial
numbers at 24 h, the levels of signal equalize by 48 h post-
administration of CNIR5, suggesting that the ﬂuorophore builds up
at the site of infection, consistent with pooling of ﬂuorophore in
the cytoplasm of infected macrophages. Lung examined ex vivo at
48 h displays a strong signal from infected animals but no signal from
uninfected animals, demonstrating that the source of the signal is
clearly within infected lungs (Fig. 5D). Localization of the source
of the signal from CNIR5 was conﬁrmed by 3D ﬂuorescence-
mediated molecular tomography (FMT) analyses in living mice
(Fig. S2). FMT of animals at 24 and 48 h consistently localizes the
signal source within the lungs and allows accurate quantiﬁcation of
the concentration of the ﬂuorochrome, as shown by the nearly
linear correlation with the number of bacteria present (Fig. S2D;
r2 = 0.863). We calculated the limit of detection for live animal
imaging using REF in mice after pulmonary infection to be 1.3 ±
0.6 × 104 CFU. Because adult human lung attenuates near-
infrared signals approximately 10-fold for every 2.5 cm of depth
(28, 29) and the sensitivity of REFoptical imaging allows detection
of low bacterial numbers (∼104 CFU) within lung, enhanced ver-
sions of this approach may offer promise for imaging tuberculosis
in a clinical setting (30).
Evaluation of Therapeutic Efﬁcacy with REF. After pulmonary in-
fection with 106 CFU, we observed measurable ﬂuorescent signal
Fig. 3. Fluorogenic compounds allow detection of
M. tuberculosis (Mtb) in vitro and direct detection of
infected cells by confocal microscopy and ﬂuorescence
activated cell sorting (FACS). (A) Correlation of ﬂuo-
rescent signal and number of tubercle bacilli in culture
as determined by colony-forming units (CFU) in the
presence of CNIR5 for 24 h. (B) Fluorescence confocal
microscopy of Mtb coincubated with the CNIR sub-
strates for 24 h demonstrates ﬂuorescence incor-
poration into the bacteria. (C) Correlation of ﬂuo-
rescent signal and number of tubercle bacilli present
within J774A.1 murine macrophages after coincubat-
ing with CNIR5 for 24 h. (D) Fluorescence confocal
microscopy of J774A.1 murine macrophages infected
with GFP (green) expressing Mtb and coincubated
with CNIR substrates (red) for 24 h. Fixed cells were
stained with DAPI (blue) to visualize nuclei. Infected
cells can be identiﬁed by the presence of signal from
CNIR substrates whereas uninfected cells do not in-
corporate CNIR signal. (E) FACS allows separation of
infected J774A.1 murine macrophages labeled with
CNIR5 in a manner that correlates well with the mul-
tiplicity of infection (MOI) bacteria per cell. Separation
can be accomplished with GFP, GFP-expressing Mtb, or
CNIR or by using both ﬂuorescent labels. ***P < 0.001:
signiﬁcantly different from ﬂuorescence of medium
alone (horizontal dashed lines in A and C) calculated
by ANOVA with the Bonferroni posttest.
Fig. 4. Fluorogenic probes allow detection of Mycobac-
terium tuberculosis (Mtb) and bacillus Calmette–Guérin
with similar sensitivity after s.c. infection. (A) Whole-body
imaging of mice s.c. infected with Mtb and administered
the indicated CNIR substrate. Images were taken 48 h
postinfection and administration of the substrate. (B) In-
oculation sites, number of bacteria present, and region of
interest used for each animal. The position of the refer-
ence measurement is indicated (R). (C) Comparison of the
signal as a function of time postinjection of each CNIR
substrate for 108 Mtb or (D) bacillus Calmette–Guérin.
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that normally increases and plateaus in signal intensity after the
ﬁrst 48 h postinfection. When rifampin and isoniazid (10 μg/mL
each) are administered together either in vitro to bacteria alone
or to infected mice, we observed a signiﬁcantly different (P < 0.01)
signal from the untreated controls within 24–48 h posttreatment
(Fig. S3). These observations conﬁrm that REF allows rapid eval-
uation of therapeutic efﬁcacy either under laboratory conditions
or during infections in mice.
Discussion
Endogenous enzymes combined with custom substrates allow
sensitive detection of bacterial infection directly in living mice, as
demonstrated by our use of REF for Mtb. The high sensitivity of
this approach is due to a combination of the fact that the substrate
does not need to gain access to the bacterial cytoplasm—only to
the surface-localized BlaC enzyme—and the ﬂuorescent product
can build up at the site of infection, enhancing signal. Previous
microarray studies indicate that BlaC is expressed constitutively by
Mtb in vivo after more than 28 d postinfection in BALB/c and
SCIDmice (31) and at least 30 d postinfection in theWaynemodel
of nonreplicating persistence (32), suggesting that BlaC will make
a good reporter under most in vivo-relevant conditions. Given that
ﬂuorogenic substrates can be developed for numerous enzymes,
including proteases, kinases, ureases, β-galactosidases, and β-
lactamases, REF technology should have utility for detection and
imaging of many pathogens. The stability of the ﬂuorescent pro-
duct ensures proper localization to infected tissue and the ability
to follow the site of infection in real time. This system displays
promise for use in detecting infection in patients where bacteria
cannot be tagged with conventional reporters before imaging
and diagnosis.
Probes for bacteria that use catalytic enzymes, as in the case of
REF, are likely to be very sensitive because they are not limited by
the number of taggedmolecules that can be delivered to the site of
infection as compared with background, but continuously pro-
duce more signal as long as substrate is available. Use of a natural
enzyme that is not expressed by the host ensures speciﬁcity and
prevents potential metabolic impacts due to heterologous gene
expression. The value of using endogenous systems for imaging is
supported by studies using thymidine kinase for SPECT (33), but
Fig. 5. Fluorogenic probes allow detection of bacillus Calmette–Guérin and Mycobacterium tuberculosis (Mtb) after pulmonary infection of mice. (A) Signal
levels from mice infected with bacillus Calmette–Guérin by the pulmonary route of inoculation that were administered CNIR5 immediately after infection or
uninfected mice that were also administered CNIR5. The yellow boxes within the ﬁrst two mouse image panels indicate the regions that were magniﬁed
fourfold to produce the images above the mouse image panels. (B) Depiction of dorsal and ventral views of a mouse with organs to provide the anatomical
context for the observed signal. (C) Whole-body images using transillumination after pulmonary infection with Mtb in mice in the same manner as in A. The
mouse on the left is uninfected but was administered the CNIR5 substrate whereas the mouse on the right is infected with Mtb by aerosol and was ad-
ministered CNIR5 immediately after infection. Images were collected at 48 h postinfection with administration of CNIR5 at the same time as infection. (D)
Lungs were harvested from infected (lower two sets of lungs) and uninfected (top lungs) animals immediately after live animal images were collected. Lungs
were harvested postmortem from the same animals that were ﬁrst imaged alive (C), and then the lungs themselves were imaged (D). The CFU means and SD
of four mice for each dose were (A) 1.3 ± 0.6 × 104, 1.1 ± 0.02 × 105, and 1.0 ± 0.2 × 106 and (C and D) 1.0 ± 0.6 × 106.
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thymidine kinase-based imaging is not an option for clinical
mycobacteria because they do not produce this enzyme and a
recombinant strain is required (9, 10). An additional beneﬁt of
BlaC as an endogenous reporter is the fact that it is available
outside the bacterial cell. The conclusion that the Mtb BlaC is
surface-localized after secretion is consistent with observations
that β-lactamase activity is associated with the surface in myco-
bacteria (15, 34, 35). The fact that BlaC is surface-localized and
expressed in all Mtb allows the ﬂuorescent product to provide
bacterial location without the need for the substrate to cross the
bacterial membrane. Hence, the sensitivity of this strategy allows
quantitative detection of Mtb both under laboratory conditions
and during animal infections.
The potential uses of this technology to facilitate tuberculosis
research are nearly limitless. We demonstrate labeling of the
bacteria, quantitative assessment of host cell infection, identiﬁ-
cation of infected cells by both microscopy and FACS, detection
of Mtb in animals, quantitative analysis of infection, and locali-
zation to speciﬁc tissues. The nearly linear correlation between
bacterial numbers and ﬂuorescence signal indicates that REF is
well suited for quantitative analysis of bacterial load during
experiments where colony-forming units are commonly used and
in animal tissues during infection or challenge studies. Because
evaluation of Mtb bacterial numbers normally requires 3 wk or
more, an immediate readout will have a profound impact on the
Mtb ﬁeld. Furthermore, considering the high sensitivity observed
for mice, this approach should be applicable to other animal
models, including rabbits and guinea pigs (36–40). Even if REF
were used in combination with colony-forming units, having in-
formation that would allow experiments to be repeated or revised
on the basis of the REF data before obtaining the CFU data
would greatly speed progress.
Our study demonstrates that Mtb can be detected and quanti-
ﬁed in living mice using custom ﬂuorescent substrates for en-
dogenous β-lactamase, which allows detailed real-time analysis
of pulmonary infections. Because BlaC is expressed by all Mtb
strains examined, it is likely that REF can be directly applied to
clinical strains and other pathogenic mycobacteria because it
utilizes a naturally produced enzyme for detection. Although the
half-life for β-lactamases can vary somewhat (41), it has been
estimated at around 206 min in mammalian cells (22), suggesting
that enzyme levels represent a reasonable surrogate for numbers
of viable bacteria. This assertion is supported by the strong cor-
relation that we observed between viable bacterial numbers and
REF signal in vitro and in animals (Fig. 3A and Fig. S2D). Thus,
REF allows real-time estimation of the bacterial load in tissues,
a key measure of virulence for attenuated mutants, efﬁcacy of
vaccines, and antimicrobial therapeutic potential. Our observa-
tion that therapeutics can be evaluated within 24–48 h with REF
supports this conclusion. The presence of β-lactamases in bacteria,
such as P. aeruginosa or methicillin-resistant S. aureus, that cause
community-acquired pneumonias (CAP) could potentially inter-
fere with REF, but the clinical presentation for tuberculosis is
frequently sufﬁciently different from CAP (42–46) that the typical
nodular lesions in the apical lobe of the lung found with tuber-
culosis are more likely to be misdiagnosed as carcinoma (46–48).
Carcinoma could be differentiated from tuberculosis using REF
imaging, making REF a potentially valuable tool in the diagnostic
arsenal. Because the Mtb BlaC enzyme has a relatively unique
active site pocket (21), studies are ongoing to further optimize the
structure of our custom probes to produce even more highly sen-
sitive and speciﬁc detection and imaging of Mtb in animals with
the hope of ultimately applying this technology directly to tuber-
culosis patients. This tool will also facilitate tuberculosis research
through accelerating progress toward development of diagnostics,
vaccines, and therapeutics.
Materials and Methods
Strains and Growth Conditions. With the exception of Fig. 1 where multiple
strains were used, Mtb strain Erdman was used for all experiments. All
strains were grown as described previously (49). Bacterial numbers were
conﬁrmed in all experiments by plating dilutions for colony-forming units.
Additional details are included in SI Materials and Methods.
Cell Lines and Culture Conditions. The murine macrophage cell line J774A.1
(ATCC TIB67) was maintained at 37 °C and 5% CO2 in high glucose Dulbecco’s
Modiﬁed Eagle Medium (DMEM; Gibco) supplemented with 10% heat-
inactivated FBS (Gibco) and 2 mM L-glutamine.
Macrophage Infection Assays. J774A.1 cells were infected as described pre-
viously (50). Additional details are included in SI Materials and Methods.
Flow Cytometry. Mtb strain CDC1551 was transformed with the vector pFJS8
that carries the L5 promoter expressing GFP (51). Flow cytometry was con-
ducted essentially as described previously (52). Additional details are included
in SI Materials and Methods.
Mouse Infections. Infections were by intratracheal instillation of 104–106 CFU to
the lungs (53) for bacillus Calmette–Guérin and aerosol using the Madison
chamber (52) for Mtb. Comparable imaging and bacterial viability data were
obtained with either route. Additional details are included in SI Materials and
Methods. Animaluseprotocolswere reviewedandapprovedbythe Institutional
Animal Care and Use Committee of Texas A&M University.
β-Lactamase Activity Assays and Fractionation. Cultures of mycobacteria
grown to early exponential phase (OD600 = 0.4) and centrifuged for 10 min at
3,000 × g to separate the bacteria from the supernatant. The supernatant
was ﬁltered through a 0.45-μm ﬁlter and retained as the culture ﬁltrate. The
pellet was washed twice with sterile PBS and resuspended to the original
volume in PBS (whole-cell fraction). A portion of the whole-cell fraction was
lysed by sonication with 30-s pulses at 60% output over 6 min on ice (crude
lysate). The crude lysate was centrifuged for 30 min at 20,000 × g at 4 °C, and
the pellet was resuspended in an equal volume of PBS (membrane fraction).
Volumes of each fraction equivalent to 107 bacteria were aliquoted into 96-
well plates for assays. Fluorocillin Green (Invitrogen) was added at 4.5 μM to
each well, and the plates were shaken gently for 5 min at room temperature
and incubated at 37 °C between 30 min and 20 h. The change in ﬂuorescence
was measured by excitation at 485 nm and emission at 530 nm.
Design and Synthesis of β-Lactamase Imaging Probes. The general principle for
probe design is FRET. Each probe contains the lactam component that will be
recognized by β-lactamase, a ﬂuorescent group, and a light absorber. Be-
cause of the FRET-based quenching effect, they are initially at the quenched
or dark state when the ﬂuorescent group is excited. β-Lactamase cleavage of
the lactam ring triggers spontaneous fragmentation that releases the light
absorber connected to the 3′ position of the lactam from the ﬂuorescent
group, thus breaking the FRET process and leading to ﬂuorescence emission.
Two near-infrared cyanine dyes (Cy5, Cy5.5) were chosen due to their long
emission wavelength that is suitable for in vivo ﬂuorescence imaging. Cor-
respondingly, we modiﬁed the nonemitting dye QSY21 as the quenching
group in the probe into a hydrophilic QSY21 disulfonate that absorbs
maximally at 649 nm and a hydrophobic QSY22 that absorbs maximally at
670 nm. Both were paired with Cy5 or Cy5.5 to make four probes, desig-
nated CNIR4, CNIR5, CNIR9, and CNIR10. CNIR5 is very stable in PBS, with
a spontaneous hydrolysis rate of 1.75 × 10−7·s−1. The enzymatic acceleration
is 3.36 × 106. All probes display good solubility in aqueous solutions due to
the sulfonate groups present. CNIR5 is soluble to at least 100 μM in water. All
probes were prepared through multiple-step organic syntheses, puriﬁed by
reverse-phase HPLC, and validated by matrix-assisted laser desorption/ioni-
zation time-of-ﬂight mass spectrometry. Additional details for synthesis are
included in SI Materials and Methods.
Imaging Tuberculosis Infections.Mice were anesthetized with isoﬂuorane and
imaged in an IVIS Spectrum (Caliper Life Sciences) with and without ﬁlters for
ﬂuorescence. Images were analyzed with Living Image Software v3.1 using
spectral unmixing algorithms to remove autoﬂuorescence, with one of the
resulting channels locked to ﬁt the emission spectrum of the appropriate
ﬂuorophore (Cy5 or Cy5.5). Representative images were randomly selected
from images of four mice for all ﬁgures. Additional details are included in SI
Materials and Methods.
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Confocal Fluorescence Microscopy. Cells were seeded in 8-well chamber slides
with 1 × 105 cells per well in 200 μL of DMEM plus 10% FBS overnight at 37 °C
in 5% CO2. The medium was removed, and GFP expressing Mtb was added to
each well at an MOI of 10 (bacteria per cell) in 200 μl of medium. The bacteria
were coincubated with the cells for 30 min and washed twice with PBS to
remove extracellular bacteria, and medium plus 200 μg/mL amikacin was
added for 2 h at 37 °C to select for intracellular bacteria. The cells were
washed twice with PBS and placed in medium plus 20 nM substrate for 24 h
at 37 °C in 5% CO2 and washed twice with PBS. The cells were stained with
10 μg/mL DAPI, washed twice with PBS, and ﬁxed in 4% paraformaldehyde in
PBS for 30 min at room temperature. After washing, the slides were dried and
mounted for confocal ﬂuorescence microscopy.
Statistical Analyses. All experiments were carried out in triplicate and re-
peated at least three times. The signiﬁcance of the results was determined
using the Student’s t test or ANOVA, as needed. P < 0.05 was considered
signiﬁcant.
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